Thoracic medical oncologist · Uniklinik Köln · Germany (DE) · Oncology
Data minimisation
Cadence target for Tier 2: 2 per year (assumption)
3 of 1 expected engagements
All engagements including drafts, newest first
| Date | Type | Format | MSL | Product | Topics | Insights | Flags | Status | |
|---|---|---|---|---|---|---|---|---|---|
| 21 Aug 2026 | Scientific exchange | In person | James Whitfield | Vantrexa | Duration of response | 0 | — | Reviewed | ENG-0065 |
| 06 Jul 2026 | Scientific exchange | Phone | James Whitfield | Vantrexa | PD-L1 testing turnaround | 1 | — | Reviewed | ENG-0104 |
| 14 Apr 2026 | Medical education | Phone | James Whitfield | Vantrexa | Comparator checkpoint monotherapyInfusion-reaction management+1 | 0 | MI request | Reviewed | ENG-0045 |
21 Aug 2026
Duration of response
06 Jul 2026
PD-L1 testing turnaround
14 Apr 2026
Comparator checkpoint monotherapy, Infusion-reaction management, Sequencing after progression
Uniklinik Köln
Thoracic medical oncologist
Community nephrologist
Academic nephrologist
Community nephrologist
Allergist
Dermatologist